{"id": "1386186631732883456", "creation": 1619327621.0, "user_id": "960129987998244865", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 4, "quote_count": 0}}, "text": "#Sinopharm, the #Chinese pharmaceutical giant, has commenced phase-1 and phase-2 clinical trials for its new recombinant #vaccine against #COVID19 in Central China's Henan Province since Saturday.\nhttps://t.co/VCmb1LaxJq", "first_save": 1634559108.199414, "hashtags": ["#SINOPHARM", "#CHINESE", "#VACCINE", "#COVID19"]}